Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Implantable defibrillator and ventricular resynchronisation].

C Jego1, J C Deharo

  • 1Département de cardiologie, Unité de rythmologie, hôpital de la Timone Adultes, Marseille.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Myocarditis after COVID-19 vaccination: A case report.

La Revue de medecine interne·2021
Same author

[Nurse's role in functional urology].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

[Particularities of African descent patient's electrocardiogram].

Annales de cardiologie et d'angeiologie·2020
Same author

[Acute autoimmune myocarditis secondary to Graves' disease: a case report].

La Revue de medecine interne·2020
Same author

[Evaluation of an "Emergency Thrombosis" care system in a university-hospital department of general emergencies].

Journal de medecine vasculaire·2019
Same author

[Cardiovascular complications of doping products].

Annales de cardiologie et d'angeiologie·2018
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Combined heart devices offer improved survival for cardiac failure patients. Implantable automatic defibrillators (IADs) and resynchronisation therapy significantly reduce mortality, especially in advanced stages.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Advanced chronic cardiac failure management has been transformed by ventricular resynchronisation pacing.
  • Despite advances, sudden cardiac death remains a significant cause of mortality in heart failure patients.

Purpose:

  • To evaluate the efficacy of combined implantable automatic defibrillator (IAD) and resynchronisation devices.
  • To assess the impact of these devices on mortality and sudden death prevention in heart failure.

Summary:

  • Combined defibrillation and resynchronisation devices are now technically feasible, overcoming initial challenges.
  • Clinical trials like COMPANION and SCD-HeFT demonstrate significant mortality reduction with these devices in heart failure stages II and III.
  • While effective, cost and technical challenges necessitate a case-by-case approach to implantation.

Related Experiment Videos

Impact:

  • These findings support increased indications for combined resynchronisation and defibrillation devices.
  • The technology offers a promising strategy for reducing mortality in heart failure patients.
  • Further research may optimize patient selection and cost-effectiveness.